 | 
|
| |
|
Titel: Strålande diagnostik utan strålning (serie: Tema hjärtat i bild) 2008 nr 43 sid 3033-7
|
Referenser:
1. Pennell DJ. Ventricular volume and mass by CMR. J Cardiovasc Magn Reson. 2002;4:507-13.
2. Bellenger NG, Davies LC, Francis JM, Coats AJ, Pennell DJ. Reduction in sample size for studies of
remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson.
2000;2:271-8.
3. Persson E, Carlsson M, Palmer J, Pahlm O, Arheden H. Evaluation of left ventricular volumes and
ejection fraction by automated gated myocardial SPECT versus cardiovascular magnetic resonance.
Clin Physiol Funct Imaging. 2005;25:135-41.
4. Van Rossum AC, Sprenger M, Visser FC, Peels KH, Valk J, Roos JP. An in vivo validation of
quantitative blood flow imaging in arteries and veins using magnetic resonance phase-shift techniques.
Eur Heart J. 1991;12:117-26.
5. Carlsson M, Cain P, Holmqvist C, Ståhlberg F, Lundbäck S, Arheden H. Total heart volume variation
throughout the cardiac cycle in humans. Am J Physiol Heart Circ Physiol. 2004;287:H243-50.
6. Arheden H, Holmqvist C, Thilén U, Hanséus K, Björkhem G, Pahlm O, Laurin S, Ståhlberg F. Left-to-
right cardiac shunts: comparison of measurements obtained with MR velocity mapping and with
radionuclide angiography. Radiology. 1999;211:453-8.
7. Higgins CB, Wagner S, Kondo C, Suzuki J, Caputo GR. Evaluation of valvular heart disease with cine
gradient echo magnetic resonance imaging. Circulation. 1991;84:I198-207.
8. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd
RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and
contractile function. Circulation. 1999;100:1992-2002.
9. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic
resonance imaging of myocardium at risk: distinction between reversible and irreversible injury
throughout infarct healing. J Am Coll Cardiol. 2000;36:1985-91.
10. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by
contrast-enhanced magnetic resonance imaging. Circulation. 2000;102:1678-83.
8
11. Arheden H, Saeed M, Higgins CB, Gao DW, Ursell PC, Bremerich J, Wyttenbach R, Dae MW,
Wendland MF. Reperfused rat myocardium subjected to various durations of ischemia: estimation of
the distribution volume of contrast material with echo-planar MR imaging. Radiology. 2000;215:520-8.
12. Arheden H, Saeefd M, Higgins CB, Gao DW, Bremerich J, Wyttenbach R, Dae MW, Wendland MF.
Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to
quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology.
1999;211:698-708.
13. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and
transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357:21-8.
14. Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, Gross M, Dietz R,
Friedrich MG. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging
differentiate acute from chronic myocardial infarction. Circulation. 2004;109:2411-6.
15. Kellman P, Aletras AH, Mancini C, McVeigh ER, Arai AE. T2-prepared SSFP improves diagnostic
confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson
Med. 2007;57:891-7.
16. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF, Jr., Arai AE. Retrospective
determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac
magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes
(DENSE) functional validations. Circulation. 2006;113:1865-70.
17. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The
use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N
Engl J Med. 2000;343:1445-53.
18. Pagano D, Fath-Ordoubadi F, Beatt KJ, Townend JN, Bonser RS, Camici PG. Effects of coronary
revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating
myocardium. Heart. 2001;85:208-12.
19. Fath-Ordoubadi F, Pagano D, Marinho NV, Keogh BE, Bonser RS, Camici PG. Coronary
revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction. Am
J Cardiol. 1998;82:26-31.
20. Beanlands RS, Hendry PJ, Masters RG, deKemp RA, Woodend K, Ruddy TD. Delay in
revascularization is associated with increased mortality rate in patients with severe left ventricular
dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography
imaging. Circulation. 1998;98:II51-6.
21. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, van Lingen A, Fioretti PM,
Visser CA. Time course of functional recovery of stunned and hibernating segments after surgical
revascularization. Circulation. 2001;104:I314-8.
22. Bax JJ, Poldermans D, Visser FC, Elhendy A, Boersma E, Cornel JH, Fiorettri PM, Visser CA. Delayed
recovery of hibernating myocardium after surgical revascularization: implications for discrepancy
between metabolic imaging and dobutamine echocardiography for assessment of myocardial viability. J
Nucl Cardiol. 1999;6:685-7.
23. Pagano D, Bonser RS, Camici PG. Myocardial revascularization for the treatment of post-ischemic
heart failure. Curr Opin Cardiol. 1999;14:506-9.
24. Di Carli MF, Maddahi J, Rokhsar S, Schelbert HR, Bianco-Batlles D, Brunken RC, Fromm B. Long-
term survival of patients with coronary artery disease and left ventricular dysfunction: implications for
the role of myocardial viability assessment in management decisions. J Thorac Cardiovasc Surg.
1998;116:997-1004.
25. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular
magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461-74.
26. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim
RJ. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic
cardiomyopathy. J Am Coll Cardiol. 2002;40:2156-64.
27. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon
J, Bock CT, Klingel K, Kandolf R, Sechtem U. Presentation, patterns of myocardial damage, and
clinical course of viral myocarditis. Circulation. 2006;114:1581-90.
28. Skouri HN, Dec GW, Friedrich MG, Cooper LT. Noninvasive imaging in myocarditis. J Am Coll
Cardiol. 2006;48:2085-93.
29. Lauer B, Niederau C, Kuhl U, Schannwell M, Pauschinger M, Strauer BE, Schultheiss HP. Cardiac
troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol. 1997;30:1354-9.
30. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with
myocarditis. Experimental and clinical correlates. Circulation. 1997;95:163-8.
9
31. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, Fritz P, Klingel K,
Kandolf R, Sechtem U. Cardiovascular magnetic resonance assessment of human myocarditis: a
comparison to histology and molecular pathology. Circulation. 2004;109:1250-8.
 3033 |
 3034 |
 3035 |
 3036 |
 3037 |